MLTX Moonlake Immunotherapeutics

held by 1 manager in Q1 2024

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.12%	3 mo	NEW	$4M	87,500

Search